Lioresal 25 mg tablete
| Name | Lioresal 25 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-455944140 |
| Active Substance | baklofen |
| Composition | jedna tableta sadrži 25 mg baklofena |
| Pharmaceutical Form | tableta |
| Manufacturer | Novartis Pharma GmbH, Nürnberg, Njemačka Novartis Farmacéutica S.A., Barcelona, Španjolska |
| Marketing Authorisation Holder | Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.07.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/323 |
| Registration Number | 381-12-01/30-17-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | M03BX01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
